69 results on '"Lutsey, Pamela L."'
Search Results
2. Association of Left Atrial Function With Incident Chronic Kidney Disease in Older Adults
3. Bleeding risk from anticoagulant thromboprophylaxis in patients with multiple myeloma: a MarketScan analysis
4. Plasma Ferritin Levels, Incident Heart Failure, and Cardiac Structure and Function: The ARIC Study
5. Chest Symptoms and Long-Term Risk of Incident Cardiovascular Disease
6. Associations of sleep characteristics in late midlife with late-life hearing loss in the Atherosclerosis Risk in Communities-Sleep Heart Health Study (ARIC-SHHS)
7. SGLT2 Inhibitors Are Associated With Reduced Cardiovascular Disease in Patients With Type 2 Diabetes: An Analysis of Real-World Data
8. OSA and Subsequent Risk of Hospitalization With Pneumonia, Respiratory Infection, and Total Infection: The Atherosclerosis Risk in Communities Study
9. Autoimmune disease and risk of postpartum venous thromboembolism
10. Case-control studies: Increasing scientific rigor in control selection
11. Cardiac Valve Disease and Prevalent and Incident CKD in Community-Dwelling Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study
12. Peripheral Artery Disease and Subsequent Risk of Infectious Disease in Older Individuals: The ARIC Study
13. Periodontal Status, C-Reactive Protein, NT-proBNP, and Incident Heart Failure: The ARIC Study
14. Association of Right Ventricular Afterload With Atrial Fibrillation Risk in Older Adults: The Atherosclerosis Risk in Communities Study
15. Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study
16. Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC Study
17. Association of Carotid Intima-Media Thickness with Brain MRI Markers in the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)
18. Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study)
19. Association of Longitudinal Changes in Cardiac Biomarkers With Atrial and Ventricular Arrhythmias (from the Atherosclerosis Risk in Communities [ARIC] Study)
20. Cognition and 20-year subsequent sleep disturbances
21. Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
22. Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi‐Ethnic Study of Atherosclerosis
23. Contrasting Associations of Prudent and Western Dietary Patterns with Risk of Developing Venous Thromboembolism
24. 25-hydroxyvitamin D, Fibroblast Growth Factor 23, and Risk of Acute Kidney Injury Over 20 Years of Follow-Up
25. Association of Life's Simple 7 with Atrial Fibrillation Burden (From the Atherosclerosis Risk in Communities Study)
26. Association of mid-life serum lipid levels with late-life brain volumes: The atherosclerosis risk in communities neurocognitive study (ARIC[sbnd]NCS)
27. Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation
28. Hematocrit and incidence of venous thromboembolism
29. May‐Thurner syndrome: History of understanding and need for defining population prevalence
30. Resting heart rate and incidence of venous thromboembolism
31. Atrial Fibrillation, Brain Volumes, and Subclinical Cerebrovascular Disease (from the Atherosclerosis Risk in Communities Neurocognitive Study [ARIC-NCS])
32. Relation of Dietary Sodium Intake With Subclinical Markers of Cardiovascular Disease (from MESA)
33. Reasons for Differences in the Incidence of Venous Thromboembolism in Black Versus White Americans
34. A prospective study of migraine history and venous thromboembolism in older adults
35. A new model to predict ischemic stroke in patients with atrial fibrillation using warfarin or direct oral anticoagulants
36. Geographic Disparities in the Incidence of Stroke among Patients with Atrial Fibrillation in the United States
37. Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer
38. Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation
39. Trends in calcium supplementation, National Health and Nutrition Examination Survey (NHANES) 1999–2014
40. Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study
41. Relation of Serum Vitamin D to Risk of Mitral Annular and Aortic Valve Calcium (from the Multi-Ethnic Study of Atherosclerosis)
42. Serum vitamin D and change in lipid levels over 5 y: The Atherosclerosis Risk in Communities study
43. Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come
44. Parathyroid Hormone and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study
45. Biomarkers of Vitamin D Status and Risk of ESRD
46. The associations of 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms, and race with risk of incident fracture-related hospitalization: Twenty-year follow-up in a bi-ethnic cohort (the ARIC Study)
47. American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function
48. Race, vitamin D–binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study
49. Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study
50. Adipokines and incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.